{"protocolSection":{"identificationModule":{"nctId":"NCT04393025","orgStudyIdInfo":{"id":"FMASU MD 142/2016"},"organization":{"fullName":"Ain Shams University","class":"OTHER"},"briefTitle":"Endovascular Stenting of Medically Refractory ICASD (Clinical and Sonographic Study)","officialTitle":"Endovascular Stenting of Medically Refractory Intracranial Arterial Stenotic (ICAS) Disease (Clinical and Sonographic Study)","acronym":"VasIntervent"},"statusModule":{"statusVerifiedDate":"2020-05","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2016-06","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2018-06","type":"ACTUAL"},"completionDateStruct":{"date":"2019-06","type":"ACTUAL"},"studyFirstSubmitDate":"2019-12-16","studyFirstSubmitQcDate":"2020-05-14","studyFirstPostDateStruct":{"date":"2020-05-19","type":"ACTUAL"},"lastUpdateSubmitDate":"2020-05-14","lastUpdatePostDateStruct":{"date":"2020-05-19","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Mohamed Ahmed Shafik Abdallah","investigatorTitle":"Clinical professor of Neurology-Faculty of Medicine-ASU","investigatorAffiliation":"Ain Shams University"},"leadSponsor":{"name":"Ain Shams University","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false,"isUsExport":false},"descriptionModule":{"briefSummary":"Cerebral Endovascular Stenting of medically refractory Intracranial Stenotic Blood Vessels with Recurrent Ischemic Strokes patients","detailedDescription":"Fifty patients were enrolled with 25 underwent Intracranial Stenting 25 received optimal medicall treatment without stenting and comparative study of primary outcome was conducted"},"conditionsModule":{"conditions":["Stroke, Ischemic"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE4"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","interventionModelDescription":"Two armed medical study","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":50,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Intracranial Stenting","type":"OTHER","description":"25 Patients presented with recurrent Ischemic CVS with Large ICSD received ICS","interventionNames":["Device: Intracranial Stenting by Intracranial Stent Device"]},{"label":"Aspirin+Clopidogrel","type":"ACTIVE_COMPARATOR","description":"25 Patients presented with recurrent Ischemic CVS with Large ICSD received optimal medical treatment","interventionNames":["Drug: Optimum medical treatment"]}],"interventions":[{"type":"DEVICE","name":"Intracranial Stenting by Intracranial Stent Device","description":"Large Intracranial Vessels with ICSD underwent catheter lab and IC stent is inserted","armGroupLabels":["Intracranial Stenting"],"otherNames":["cardiac and wingspan IC stent device"]},{"type":"DRUG","name":"Optimum medical treatment","description":"Optimum Medical treatment","armGroupLabels":["Aspirin+Clopidogrel"],"otherNames":["Clopidogrel 75 mg +Aspirin 161 mg"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Clinical improvement of IC stented patients in comparison to medically treated","description":"clinical assessment by National Institute of Health Stroke Scale (NIHSS) for clinical impr","timeFrame":"3 months"},{"measure":"Functional improvement of IC stented patients in comparison to medically treated","description":"Functional assessment by modified Rankin Scale (mRS) for functional improvement","timeFrame":"3 months"},{"measure":"Blood flow velocity accrossed Stenotic Large IC Vessels in comparison to medically treated","description":"Transcranial doppler (TCD) assessment of Mean Flow Velocity (MFV) across IC vessels","timeFrame":"3 months"}],"secondaryOutcomes":[{"measure":"No Recurrent Ischemic stroke in stented ICSD patients","description":"Clinical Assessment","timeFrame":"6 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Patients age between 30-80 years.\n2. Symptomatic ICAS: presented with TIA or stroke, attributed to 70%-99% stenosis of a major intracranial artery: Internal carotid artery (ICA), middle cerebral artery (MCA) \\[M1segment\\], vertebral artery (VA), or basilar artery (BA).\n3. Patient with recurrent TIA or stroke despite medical therapy, including anti-coagulation or antiplatelet and control of all vascular risk factors (DM, HTN and Hyperlipidemia).\n\nExclusion Criteria:\n\n1. Patients previously stented at the target lesion or had extracranial stenosis.\n2. Patient with acute stroke (within two weeks from the onset).\n3. Complete occlusion of the artery on the imaging assessment.\n4. Massive cerebral infarction (more than half the MCA territory), intracranial hemorrhage, epidural or subdural hemorrhage, and intracranial brain tumor on CT or MRI scans.\n5. Contraindications to antithrombotic and/or anticoagulant therapies.","healthyVolunteers":false,"sex":"ALL","minimumAge":"30 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000083242","term":"Ischemic Stroke"}],"ancestors":[{"id":"D000020521","term":"Stroke"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Stroke, Ischemic","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000077144","term":"Clopidogrel"}],"ancestors":[{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000010975","term":"Platelet Aggregation Inhibitors"},{"id":"D000058921","term":"Purinergic P2Y Receptor Antagonists"},{"id":"D000058919","term":"Purinergic P2 Receptor Antagonists"},{"id":"D000058914","term":"Purinergic Antagonists"},{"id":"D000058905","term":"Purinergic Agents"},{"id":"D000018377","term":"Neurotransmitter Agents"}],"browseLeaves":[{"id":"M4238","name":"Aspirin","relevance":"LOW"},{"id":"M1669","name":"Clopidogrel","asFound":"Results","relevance":"HIGH"},{"id":"M13555","name":"Platelet Aggregation Inhibitors","relevance":"LOW"},{"id":"M28984","name":"Purinergic P2Y Receptor Antagonists","relevance":"LOW"},{"id":"M20194","name":"Neurotransmitter Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"Antipy","name":"Antipyretics"},{"abbrev":"Infl","name":"Anti-Inflammatory Agents"},{"abbrev":"ARhu","name":"Antirheumatic Agents"},{"abbrev":"FiAg","name":"Fibrinolytic Agents"},{"abbrev":"Analg","name":"Analgesics"},{"abbrev":"PlAggInh","name":"Platelet Aggregation Inhibitors"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}